Filing search / Kineta, Inc. / "Safety" / Page 10

424B5

99sub 2myf

24 Oct 18

Prospectus supplement for primary offering

4:21pm

424B5

0gpt m946qx

22 Oct 18

Prospectus supplement for primary offering

9:50pm

8-K

vld6f epib7b10

17 Oct 18

Proteostasis Therapeutics Announces Positive Preliminary Results from

4:30pm

8-K

EX-99.1

scpqin5m lvc

17 Oct 18

Proteostasis Therapeutics Announces Positive Preliminary Results from

4:30pm

8-K

EX-99.2

0ulkm4jj

17 Oct 18

Proteostasis Therapeutics Announces Positive Preliminary Results from

4:30pm

8-K

EX-99.1

7ssjfddfbxsxnxa

3 Oct 18

Regulation FD Disclosure

8:01am

8-K

EX-99.1

1um4daykwstf72ssv

26 Jul 18

Regulation FD Disclosure

7:59am

8-K

EX-99.2

bydj0o

6 Jun 18

Proteostasis Announces Positive Data from Ongoing Phase 1 Study ofPTI-801 in Cystic Fibrosis Patients on Background Orkambi® Therapy

4:11pm

8-K

EX-99.1

bnmqjizds0a k6

6 Jun 18

Proteostasis Announces Positive Data from Ongoing Phase 1 Study ofPTI-801 in Cystic Fibrosis Patients on Background Orkambi® Therapy

4:11pm

8-K

yhx 4jdoqg1nb42m

6 Jun 18

Proteostasis Announces Positive Data from Ongoing Phase 1 Study ofPTI-801 in Cystic Fibrosis Patients on Background Orkambi® Therapy

4:11pm

8-K

EX-99.1

qfp2b4gtv4jy

7 Jun 17

Proteostasis Therapeutics Announces Clinical and Regulatory Progress Across Pipeline Programs

12:00am

10-Q

a7jc3o sa

13 May 16

Quarterly report

12:00am